EPILEPSY CENTER

Providing consultative epilepsy evaluation and treatment of patients.

EPILEPSY CENTER

Providing consultative epilepsy evaluation and treatment of patients.

ABOUT US

The WVU Epilepsy Center offers clinical, research, and educational services to patients with epilepsy.

The WVU Epilepsy Center focuses on providing consultative epilepsy evaluation and treatment of patients. Following treatment, patients typically return to their primary neurologist for long-term treatment and follow-up.

State-of-the art facilities and equipment are available for diagnostic studies and treatment, including intracranial electrode implantation, cortical stimulation studies, specialized EEG procedures, and a full range of structural and functional imaging tests.

MULTI-DISCIPLINARY CLINICS

The center offers adult, pediatric, and multi-disciplinary epilepsy clinics that can help evaluate and manage epilepsy and seizures.  In addition, our providers can provide guidance on the latest surgical treatment options for epilepsy and offer care in a supportive environment. Our goal is to help patients manage the disease in order to live a richer and fuller life.

MINIMALLY INVASIVE TREATMENTS

Every year, about 150,000 Americans are diagnosed with epilepsy, a central nervous system disorder that causes seizures. With treatment, about 70 percent of people with epilepsy can go into remission. Progress in epilepsy testing and new minimally invasive surgical treatments are more effective than ever before.

Learn more in this interview with Peter Konrad, MD, chair of the Department of Neurosurgery at the WVU Rockefeller Neuroscience Institute.

Level 4 Epilepsy Center

WVU’s Epilepsy Center provides state-of-the-art care for adults and children who have seizures. Our level 4 center, active since 2002, helps patients throughout the region.NAEC Level 3 Epilepsy Center
Level 4 is the highest level awarded by the National Association of Epilepsy Centers. This label means that we help people from around the region and across the country, giving them the most up-to-date therapy for epilepsy.